Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.creatorMilagro-Yoldi, F.I. (Fermín Ignacio)-
dc.creatorMartinez, J.A. (José Alfredo)-
dc.date.accessioned2013-09-17T08:28:07Z-
dc.date.available2013-09-17T08:28:07Z-
dc.date.issued2013-
dc.identifier.citationMilagro FI, Martínez JA. Epigenética en obesidad y diabetes tipo 2: papel de la nutrición, limitaciones y futuras aplicaciones. Rev Chil Endocrinol Diabetes. 2013 Jun;6(3):108-114es_ES
dc.identifier.issn0718-493X-
dc.identifier.urihttps://hdl.handle.net/10171/29685-
dc.description.abstractIn the last years, epigenetics is helping to explain the mechanisms non dependent on the genetic sequence by which the nutrients and other environmental factors contribute to modulate gene expression and disease development. Obesity and type 2 diabetes are two diseases that have been linked to changes in epigenetic marks (particularly DNA methylation, covalent modifications of histones and miRNAs). These epigenetic changes appear to be influenced, mainly in the perinatal period but also in adulthood, by environmental factors such as hyperglycemia or the diet. Among the food compounds that have been linked to epigenetic modifications, there are methyl donor groups, excessive or deficient caloric intake, short chain fatty acids, some minerals and antioxidant vitamins, and various compounds of plant origin, as catechins, isoflavones or isothiocyanates. EWAS studies, that analyze the methylation of thousands of CpG sites in thousands of individuals, will contribute in the next years to identify some of the epigenetic marks that can be used as early predictors of metabolic risk, as well as some intimate mechanisms that explain the development of obesity, type 2 diabetes and its complications. Moreover, epigenetic marks, among them the CpG-SNPs, can be heritable but some of them could be potentially reversible. One of the medium-term objectives is to develop drug or diet-related treatments that could delay or even reverse these epigenetic changes.es_ES
dc.language.isospaes_ES
dc.publisherSociedad Chilena de Endocrinología y Diabeteses_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectEpigeneticses_ES
dc.subjectHistoneses_ES
dc.subjectDNA methylationes_ES
dc.subjectObesityes_ES
dc.subjectType 2 diabeteses_ES
dc.titleEpigenética en obesidad y diabetes tipo 2: papel de la nutrición, limitaciones y futuras aplicacioneses_ES
dc.title.alternativeEpigenetics in obesity and type 2 diabetes: role of nutrition, limitations and future applicationses_ES
dc.typeArticuloes_ES
dc.relation.publisherversionhttp://www.soched.cl/Revista%20Soched/actual.aspes_ES
dc.type.driverinfo:eu-repo/semantics/articlees_ES

Ficheros en este ítem:
Vista previa
Fichero
RevChilMartinez2013.pdf
Descripción
Tamaño
2.13 MB
Formato
Adobe PDF


Estadísticas e impacto
0 citas en
0 citas en

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.